Vaxcyte (PCVX) Depreciation & Amortization (CF) (2019 - 2026)
Vaxcyte's Depreciation & Amortization (CF) was $5.78 million in Q3 2026, up 88.6% from $3.06 million a year earlier and up 92.5% from the prior quarter.
Powered by 
Analysis
Vaxcyte (PCVX) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Vaxcyte's Depreciation & Amortization (CF) was $19.22 million through Sep 30, 2026, up 63.4% year-over-year; for FY2025, it came in at $16.4 million, up 134.1% from FY2024.
- Depreciation & Amortization (CF) has now increased for seven consecutive years, with a five-year compound annual growth rate of 63.5% (FY2020 to FY2025).
- In earlier years, Depreciation & Amortization (CF) was $7 million in FY2024 (+121.9%), $3.16 million in FY2023 (+11.4%), $2.83 million in FY2022 (+57.4%) and $1.8 million in FY2021 (+28.1%).
- Quarterly Depreciation & Amortization (CF) has moved between $459,000 (Q4 2021) and $7.5 million (Q4 2025) over five years.
- Compared with a year earlier, Depreciation & Amortization (CF) was higher in seven of the last eight quarters, with growth averaging 107.1%.
- The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q4 2024 (growth of 222.5%); the worst was Q4 2023 (a decline of 7.4%).
- Per Business Quant data, PCVX's Depreciation & Amortization (CF) in the three quarters before Q3 2026 was $3 million (Q2 2026), $2.95 million (Q1 2026) and $7.5 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 545.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.12 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 192.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 726.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.61 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.12 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 132.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.58 Bn |
| 10 | Vaxcyte | 9.91 Bn | 3.83 Bn | - | 5.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.78 Mn |
| Jun 30, 2026 | 3.00 Mn |
| Mar 31, 2026 | 2.95 Mn |
| Dec 31, 2025 | 7.50 Mn |
| Sep 30, 2025 | 3.06 Mn |
| Jun 30, 2025 | 2.88 Mn |
| Mar 31, 2025 | 2.96 Mn |
| Dec 31, 2024 | 2.86 Mn |
| Sep 30, 2024 | 1.79 Mn |
| Jun 30, 2024 | 1.35 Mn |
| Mar 31, 2024 | 999,000.00 |
| Dec 31, 2023 | 888,000.00 |
| Sep 30, 2023 | 806,000.00 |
| Jun 30, 2023 | 750,000.00 |
| Mar 31, 2023 | 712,000.00 |
| Dec 31, 2022 | 959,000.00 |
| Sep 30, 2022 | 684,000.00 |
| Jun 30, 2022 | 609,000.00 |
| Mar 31, 2022 | 582,000.00 |
| Dec 31, 2021 | 459,000.00 |
API Access
Vaxcyte Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=PCVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "PCVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=PCVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();